Home › Neurofibrosarcoma › New York › New York City
Neurofibrosarcoma clinical trials in New York City, NY
6 studies for Neurofibrosarcoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- New York University Langone Health, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecruitingPhase 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Memorial Sloan Kettering Kids, New York
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Neurofibrosarcoma trials in other cities
- Washington, DC6 studies
- St. Louis, MO4 studies
- Boston, MA4 studies
- Cincinnati, OH3 studies
- Mountain View, CA3 studies
- Houston, TX3 studies
- Chicago, IL3 studies
- Queens, NY3 studies
- Edison, NJ3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.